Introduction
higher titer in patients with active Wegener's granulomatosis compared to patients with quiescent disease [6 ] . Antineutrophil cytoplasmic autoantibodies (ANCA) Subsequently, there have been many publications that are specific for antigens in the cytoplasm of neutrophils have addressed the correlation between ANCA titer and monocytes. Approximately 90% of ANCA in and the clinical course of the disease [2] . Although patients with vasculitis or glomerulonephritis have there is controversy over whether or not the correlation specificity for either myeloperoxidase (MPO) or prois close enough to be used for making therapeutic teinase 3 (PR3), which are located in the primary decisions, there is general agreement that there is at granules of neutrophils and the peroxidase-positive least a rough positive correlation between ANCAlysosomes of monocytes.
positivity and disease activity. This is consistent with Beginning with the initial publication about ANCA a cause and effect relationship, but would also occur [1] , they have been strongly associated with a spectrum with an epiphenomenon that was secondary to active of necrotizing small vessel vasculitides that includes Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome [2, 3] . These vasculitides often have necrotizing and crescentic glomerulo- between human MPO bound to vessel walls and anticause disease remission by abrogating secondary mediator events rather than primary (aetiological ) immuno-MPO. One explanation for this model is that the low level in situ immune complex formation acts as a nidus logical events. The apparent effectiveness of pooled intravenous immune globulin in patients with ANCA-for amplification of inflammation by ANCA (i.e. anti-MPO); in other words, low level neutrophil activation vasculitis is somewhat more supportive of an antibodymediated pathogenic process [7] .
initiated by the scanty immune complex formation is driven to severe acute inflammation by the presence of The most compelling clinical evidence that ANCA cause vasculitis and glomerulonephritis is the observa-ANCA. This might be analogous to the development of severe crescentic glomerulonephritis in ANCA-posittion that certain drugs, such as thiouracils, hydralazine, and penicillamine, are capable of inducing ANCA ive humans who have a pattern of immune complex glomerulonephritis that usually would not induce formation that is associated with the development of small vessel vasculitis and glomerulonephritis, which severe inflammation. For example, patients with a membranous glomerulopathy pattern of immune comis pathologically identical to idiopathic pauci-immune ANCA-vasculitis and glomerulonephritis. This phe-plex deposition who have ANCA develop severe crescentic glomerulonephritis, possibly because the ANCA nomenon has been described most often with propylthiouracil treatment [8] [9] [10] [11] . For example, Tanemoto et al. is driving the membranous glomerulopathy to a more inflammatory and necrotizing phenotype. [10] and D'Cruz et al. [11] have described five Grave's disease patients who developed biopsy-proven pauciKobayashi et al. reported observations that also suggest that ANCA can synergize with other pathoimmune crescentic glomerulonephritis after treatment with propylthiouracil. The disease resolved after with-genic factors to cause disease [16 ] . They observed that rats injected with low doses of anti-GBM antibodies drawal of the drug and immunosuppressive treatment.
along with anti-MPO antibodies developed more severe glomerular neutrophil infiltration and fibrin formation than rats injected with anti-GBM or anti-MPO alone.
In vivo evidence that ANCA are pathogenic
Recently, Heeringa et al. have reported results that extend the work of Kobayashi [17] . They immunized rats with human MPO, resulting in the production of There are no experimental models that closely resemble pauci-immune ANCA-vasculitis or pauci-immune circulating anti-MPO that reacted with human and rat MPO. Subsequent injection of subnephritogenic doses ANCA-glomerulonephritis, although there are an increasing number of models that appear to simulate of anti-GBM antibodies caused crescentic glomerulonephritis in rats with circulating anti-MPO (i.e. certain ANCA-positive human disease states.
Approximately 20% of humans with systemic lupus ANCA), whereas rats that had not been immunized with MPO developed only insignificant glomerular erythematosus have ANCA, usually with specificity for MPO. Two strains of mice with polyclonal B cell lesions. This model further substantiates that ANCA can markedly amplify acute inflammatory events that activation and some pathological features that resemble lupus also have an~20% frequency of are set into motion by stimuli that otherwise would cause only minor leukocyte activation. ANCA, usually with specificity for MPO [12, 13] . These mice develop vasculitis and glomerulonephritis, but the Shoenfeld et al. have used a different strategy to induce ANCA in experimental animals [18, 19] . They pathogenic role for ANCA is uncertain because only a minority of mice have ANCA and there are many injected human ANCA with anti-PR3 specificity into the dermis of mice resulting in the formation of other potentially pathogenic autoantibodies in addition to ANCA in these mice.
an anti-idiotypic antibody network. The anti-antiidiotypic antibodies (Ab3) had anti-PR3 antigen speciMercury treatment of Brown Norway rats induces polyclonal B cell activation and the generation of ficity that mimicked the specificity of the human ANCA used for immunization. Although these mice multiple autoantibodies, including ANCA [14] . These animals develop vasculitis, especially in the gut. This developed minor pulmonary inflammatory lesions, the injury did not closely resemble ANCA-vasculitis. model may be analogous to human drug-induced ANCA, which also is characterized by production of Thus, there is no ideal animal model for pauciimmune ANCA-vasculitis in humans. The models of multiple autoantibodies. Once again, however, the presence of many different autoantibodies makes it Brouwer and Heeringa [15, 17] 
The mechanism by which ANCA activate primed a number of in vitro observations that indicate the neutrophils is not completely understood. There is ability of ANCA to activate neutrophils that have been controversy over the relative roles of Fab∞2 binding stimulated (primed ) to express ANCA-antigens on versus Fc receptor engagement in the activation protheir surfaces.
cess. Immune complex formation between ANCA and ANCA-antigens would be expected on the surface of neutrophils and in the microenvironment immediately
In vitro evidence that ANCA are pathogenic around primed neutrophils that are surrounded by the plasma or interstitial fluid of an ANCA-positive indiWhatever the initiating event in patients with necrotiz-vidual. This would result in engagement of neutrophil ing vasculitis, there must be a final common pathway Fc receptors by the microenvironmental immune comof injury that entails (i) leukocyte margination, adher-plexes. Such a scenario is supported by in vitro experience, and diapedesis, (ii) leukocyte activation with ments that have indicated a role for Fc receptor degranulation and generation of toxic oxygen metabol-engagement in the process of ANCA-induced neutroites, and (iii) vascular necrosis with fibrinous insud-phil activation [22, 23] Full activation of neutrophils and monocytes at sites PR3). There are in vitro experimental data that support of acute inflammation results in extensive release of each of these possibilities, which suggests that ANCA highly charged ANCA-antigens that are capable of may initiate or augment inflammation by multiple binding to cellular and matrix structures and thus synergistic mechanisms ( Figure 1) . acting as niduses for in situ immune complex formation Any elucidation of a pathogenic mechanism that with ANCA. Vargunam et al. have demonstrated in involves ANCA must explain how the autoantibodies vitro that MPO binds to endothelial cells and thus is are able to interact with antigens that are sequestered available to act as a planted antigen to interact with within the cytoplasm of neutrophils and monocytes.
ANCA [30] . The Brouwer model of MPO-induced In vitro experiments have demonstrated that exposure glomerulonephritis and vasculitis may involve a subof neutrophils to low doses of cytokines (e.g. tumour stantial component of in situ MPO-anti-MPO formanecrosis factor alpha, TNF ) results in expression of tion, at least during the early phases [15] . If in situ small amounts of ANCA-antigens (e.g. MPO and PR3) ANCA immune complex formation occurs in the tisat the cell surface, which can be detected by flow sues of patients with pauci-immune ANCA-vasculitis, cytometry and immunoelectron microscopy [20, 21] . If it must be at very low levels because immunohistology the cytokine dose is low enough, the neutrophils are usually demonstrates no IgG staining at sites of primed to express ANCA-antigens but are not driven ANCA-vasculitis. Nevertheless, low levels of immune to full activation. Exposure of cytokine-primed neutrocomplexes may be present and may add fuel to the fire phils to ANCA IgG induces full activation with a respiratory burst that generates toxic oxygen metabol-of ANCA-induced inflammation. (Figure 1 ). The ultimate necrotizing cytotoxic effects on endothelial cells [32] . In contrast, injury to vessel walls involves apoptotic and necrotizing King et al. were unable to detect PR3 in cytokine-death of leukocytes and vascular cells, as well as lysis stimulated human umbilical cord endothelial cells by of matrix, caused by oxygen metabolites and enzymes immunohistology or enzyme immunoassay, and they release by activated leukocytes. were also unable to detect PR3 RNA message by PCR In patients with circulating ANCA, a synergistic [33] . Thus, the importance of PR3 synthesis by endo-inflammatory event, such as an infection, may prime thelial cells is unresolved. neutrophils and monocytes in the circulation to interact Several clinical observations suggest that some of with ANCA, resulting in activation, microvascular the in vitro observations are paralleled by events in adherence and subsequent vascular inflammatory vivo. The onset and exacerbations of ANCA-vasculitis injury, especially at sites where leukocytes are in close typically are preceded by flu-like symptoms, such as contact with vessel walls, such as in the renal glomerfever, myalgias and arthralgias, which suggest the ular and pulmonary alveolar capillaries. In addition, presence of increased levels of circulating cytokines neutrophils and monocytes that are in the process of that could be priming neutrophils for interaction with adhering to and migrating through vessel walls at sites ANCA. Such increased levels of circulating cytokines of inflammation initiated by a synergistic process, such have been documented in patients with vasculitis as a respiratory tract infection, would be prematurely [34] [35] [36] , and circulating neutrophils in patients with driven to full activation, resulting in vascular ANCA-vasculitis have surface expression of ANCA-inflammation and necrosis. antigens [37] .
